These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 16200208)
21. Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Li P; Wang D; Lucas J; Oparil S; Xing D; Cao X; Novak L; Renfrow MB; Chen YF Circ Res; 2008 Feb; 102(2):185-92. PubMed ID: 17991884 [TBL] [Abstract][Full Text] [Related]
22. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521 [TBL] [Abstract][Full Text] [Related]
23. Mechanisms of hepatocyte protection against hypoxic injury by atrial natriuretic peptide. Carini R; De Cesaris MG; Splendore R; Domenicotti C; Nitti MP; Pronzato MA; Albano E Hepatology; 2003 Feb; 37(2):277-85. PubMed ID: 12540777 [TBL] [Abstract][Full Text] [Related]
24. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling. Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244 [TBL] [Abstract][Full Text] [Related]
25. Down-regulation of C-type natriuretic peptide receptor by vasonatrin peptide in cardiac myocytes and fibroblasts. Lü SY; Zhu MZ; Wang DS; Yu J; Guo HT; Hu YZ; Wei QM Acta Pharmacol Sin; 2004 Apr; 25(4):424-30. PubMed ID: 15066207 [TBL] [Abstract][Full Text] [Related]
26. Anti-hypertrophic effects of oxytocin in rat ventricular myocytes. Menaouar A; Florian M; Wang D; Danalache B; Jankowski M; Gutkowska J Int J Cardiol; 2014 Jul; 175(1):38-49. PubMed ID: 24852833 [TBL] [Abstract][Full Text] [Related]
32. A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1-calcineurin pathway. Kilic A; Rajapurohitam V; Sandberg SM; Zeidan A; Hunter JC; Said Faruq N; Lee CY; Burnett JC; Karmazyn M Cardiovasc Res; 2010 Dec; 88(3):434-42. PubMed ID: 20679416 [TBL] [Abstract][Full Text] [Related]
33. Nitric oxide regulates AKT phosphorylation and nuclear translocation in cultured retinal cells. Mejía-García TA; Portugal CC; Encarnação TG; Prado MA; Paes-de-Carvalho R Cell Signal; 2013 Dec; 25(12):2424-39. PubMed ID: 23958999 [TBL] [Abstract][Full Text] [Related]
34. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5. Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342 [TBL] [Abstract][Full Text] [Related]
35. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation. Ni XP; Safai M; Gardner DG; Humphreys MH Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387 [TBL] [Abstract][Full Text] [Related]
36. Ischemic preconditioning triggers nuclear translocation of thioredoxin and its interaction with Ref-1 potentiating a survival signal through the PI-3-kinase-Akt pathway. Malik G; Gorbounov N; Das S; Gurusamy N; Otani H; Maulik N; Goswami S; Das DK Antioxid Redox Signal; 2006; 8(11-12):2101-9. PubMed ID: 17034353 [TBL] [Abstract][Full Text] [Related]
37. Functional receptors for atrial natriuretic peptide in the rat mammary gland during lactation. Cvek K; Ridderstråle Y; Gerstberger R Endocrinology; 1998 May; 139(5):2615-21. PubMed ID: 9564878 [TBL] [Abstract][Full Text] [Related]
38. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation. Fürst R; Brueckl C; Kuebler WM; Zahler S; Krötz F; Görlach A; Vollmar AM; Kiemer AK Circ Res; 2005 Jan; 96(1):43-53. PubMed ID: 15569826 [TBL] [Abstract][Full Text] [Related]